North Valley Hematology/Oncology Medical Group

Mission Hills, California 91345

0 studies enrolling now · 4 studies all time

What they study most

Bladder Cancer, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin, Mantle Cell Lymphoma, Metastasis, Prostate Cancer, Transitional Cell Carcinoma

Studies at this site

• First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy — Completed
• Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) — Stopped early
• Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma — Completed
• Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments — Completed